Controlled Angiogenesis in Peptide Nanofiber Composite Hydrogels

ACS Biomaterials Science and Engineering

Volumn 1, Issue 9, 2015, Pages 845-854

  Wickremasinghe, Navindee C ^a   Kumar, Vivek A ^a   Shi, Siyu ^a   Hartgerink, Jeffrey D ^a,b  

^a RICE UNIVERSITY   (United States)

^b Rice University   (United States)

Author keywords

angiogenesis; cellular infiltration; liposomal encapsulation; multidomain peptide; PlGF 1; self assembly

Indexed keywords

LIPOSOME; NANOFIBER; PEPTIDE; PLACENTAL GROWTH FACTOR; PLACENTAL GROWTH FACTOR 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL DENSITY; CELL MEMBRANE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; HEART MUSCLE ISCHEMIA; HYDROGEL; IN VITRO STUDY; LIPID BILAYER; MACROPHAGE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATIVE MEDICINE; WISTAR RAT;

EID: 84969261969     PISSN: None     EISSN: 23739878     Source Type: Journal    
DOI: 10.1021/acsbiomaterials.5b00210     Document Type: Article

References (67)

1. Freedman, S. B. Therapeutic Angiogenesis for Coronary Artery Disease Ann. Intern. Med. 2002, 136 (1) 54 10.7326/0003-4819-136-1-200201010-00011
2. Losordo, D. W.; Dimmeler, S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines Circulation 2004, 109 (21) 2487-2491 10.1161/01.CIR.0000128595.79378.FA
3. Phelps, E. A.; Garcia, A. J. Update on therapeutic vascularization strategies Regener. Med. 2009, 4 (1) 65-80 10.2217/17460751.4.1.65
4. Sun, Q.; Chen, R. R.; Shen, Y.; Mooney, D. J.; Rajagopalan, S.; Grossman, P. M. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb Pharm. Res. 2005, 22 (7) 1110-1116 10.1007/s11095-005-5644-2
5. Scott, R. C.; Rosano, J. M.; Ivanov, Z.; Wang, B.; Chong, P. L.-G.; Issekutz, A. C.; Crabbe, D. L.; Kiani, M. F. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function FASEB J. 2009, 23 (10) 3361-3367 10.1096/fj.08-127373
6. Luttun, A.; Tjwa, M.; Moons, L.; Wu, Y.; Angelillo-Scherrer, A.; Liao, F.; Nagy, J. A.; Hooper, A.; Priller, J.; De Klerck, B. et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Nat. Med. 2002, 8 (8) 831-840 10.1038/nm731
7. Tjwa, M.; Luttun, A.; Autiero, M.; Carmeliet, P. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis Cell Tissue Res. 2003, 314 (1) 5-14 10.1007/s00441-003-0776-3
8. Barrientos, S.; Stojadinovic, O.; Golinko, M. S.; Brem, H.; Tomic-Canic, M. Growth factors and cytokines in wound healing Wound Repair Regen. 2008, 16 (5) 585-601 10.1111/j.1524-475X.2008.00410.x
9. Carmeliet, P.; Moons, L.; Luttun, A.; Vincenti, V.; Compernolle, V.; De Mol, M.; Wu, Y.; Bono, F.; Devy, L.; Beck, H. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat. Med. 2001, 7 (5) 575-583 10.1038/87904
10. Richardson, T. P.; Peters, M. C.; Ennett, A. B.; Mooney, D. J. Polymeric system for dual growth factor delivery Nat. Biotechnol. 2001, 19 (11) 1029-1034 10.1038/nbt1101-1029
11. Zhou, L.; Chen, Z.; Vanderslice, P.; So, S.-P.; Ruan, K.-H.; Willerson, J. T.; Dixon, R. A. F. Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits Circulation 2013, 128 (9) 982-994 10.1161/CIRCULATIONAHA.113.003139
12. Madonna, R.; Ferdinandy, P.; De Caterina, R.; Willerson, J. T.; Marian, A. J. Recent developments in cardiovascular stem cells Circ. Res. 2014, 115 (12) e71-e78 10.1161/CIRCRESAHA.114.305567
13. Willerson, J. T.; Taylor, D.; Perin, E. C. Till truth makes all things plain: human hearts and stem cells Circ. Res. 2014, 115 (11) 908-910 10.1161/CIRCRESAHA.114.305340
14. Kocher, A. A.; Schuster, M. D.; Szabolcs, M. J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N. M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat. Med. 2001, 7 (4) 430-436 10.1038/86498
15. Kumar, V. A.; Taylor, N. L.; Shi, S.; Wang, B. K.; Jalan, A. A.; Kang, M. K.; Wickremasinghe, N. C.; Hartgerink, J. D. Highly angiogenic Peptide nanofibers ACS Nano 2015, 9 (1) 860-868 10.1021/nn506544b
16. Kumar, D.; Branch, B. G.; Pattillo, C. B.; Hood, J.; Thoma, S.; Simpson, S.; Illum, S.; Arora, N.; Chidlow, J. H.; Langston, W. et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis Proc. Natl. Acad. Sci. U. S. A. 2008, 105 (21) 7540-7545 10.1073/pnas.0711480105
17. Lundberg, J. O.; Weitzberg, E.; Gladwin, M. T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics Nat. Rev. Drug Discovery 2008, 7 (2) 156-167 10.1038/nrd2466
18. Galler, K. M.; Aulisa, L.; Regan, K. R.; D'Souza, R. N.; Hartgerink, J. D. Self-assembling multidomain peptide hydrogels: designed susceptibility to enzymatic cleavage allows enhanced cell migration and spreading J. Am. Chem. Soc. 2010, 132 (9) 3217-3223 10.1021/ja910481t
19. Bakota, E. L.; Aulisa, L.; Galler, K. M.; Hartgerink, J. D. Enzymatic cross-linking of a nanofibrous peptide hydrogel Biomacromolecules 2011, 12 (1) 82-87 10.1021/bm1010195
20. Galler, K. M.; Hartgerink, J. D.; Cavender, A. C.; Schmalz, G.; D'Souza, R. N. A customized self-assembling peptide hydrogel for dental pulp tissue engineering Tissue Eng., Part A 2012, 18 (1-2) 176-184 10.1089/ten.tea.2011.0222
21. Kang, M. K.; Colombo, J. S.; D'Souza, R. N.; Hartgerink, J. D. Sequence effects of self-assembling multidomain peptide hydrogels on encapsulated SHED cells Biomacromolecules 2014, 15 (6) 2004-2011 10.1021/bm500075r
22. Wickremasinghe, N. C.; Kumar, V. A.; Hartgerink, J. D. Two-step self-assembly of liposome-multidomain peptide nanofiber hydrogel for time-controlled release Biomacromolecules 2014, 15 (10) 3587-3595 10.1021/bm500856c
23. Aulisa, L.; Dong, H.; Hartgerink, J. D. Self-assembly of multidomain peptides: sequence variation allows control over cross-linking and viscoelasticity Biomacromolecules 2009, 10 (9) 2694-2698 10.1021/bm900634x
24. Dong, H.; Paramonov, S. E.; Aulisa, L.; Bakota, E. L.; Hartgerink, J. D. Self-assembly of multidomain peptides: balancing molecular frustration controls conformation and nanostructure J. Am. Chem. Soc. 2007, 129 (41) 12468-12472 10.1021/ja072536r
25. Bakota, E. L.; Sensoy, O.; Ozgur, B.; Sayar, M.; Hartgerink, J. D. Self-assembling multidomain peptide fibers with aromatic cores Biomacromolecules 2013, 14 (5) 1370-1378 10.1021/bm4000019
26. Bakota, E. L.; Wang, Y.; Danesh, F. R.; Hartgerink, J. D. Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretome Biomacromolecules 2011, 12 (5) 1651-1657 10.1021/bm200035r
27. Xu, D.; Jiang, L.; Singh, A.; Dustin, D.; Yang, M.; Liu, L.; Lund, R.; Sellati, T. J.; Dong, H. Designed supramolecular filamentous peptides: balance of nanostructure, cytotoxicity and antimicrobial activity Chem. Commun. (Cambridge, U. K.) 2015, 51 (7) 1289-1292 10.1039/C4CC08808E
28. Kumar, V. A.; Taylor, N. L.; Shi, S.; Wickremasinghe, N. C.; D'Souza, R. N.; Hartgerink, J. D. Self-assembling multidomain peptides tailor biological responses through biphasic release Biomaterials 2015, 52, 71-78 10.1016/j.biomaterials.2015.01.079
29. Kumar, V. A.; Shi, S.; Wang, B. K.; Li, I.-C.; Jalan, A. A.; Sarkar, B.; Wickremasinghe, N. C.; Hartgerink, J. D. Drug-triggered and cross-linked self-assembling nanofibrous hydrogels J. Am. Chem. Soc. 2015, 137 (14) 4823-4830 10.1021/jacs.5b01549
30. Samad, A.; Sultana, Y.; Aqil, M. Liposomal drug delivery systems: an update review Curr. Drug Delivery 2007, 4 (4) 297-305 10.2174/156720107782151269
31. Vemuri, S.; Rhodes, C. Preparation and characterization of liposomes as therapeutic delivery systems: a review Pharm. Acta Helv. 1995, 70 (2) 95-111 10.1016/0031-6865(95)00010-7
32. Li, F.; Sun, J.-Y.; Wang, J.-Y.; Du, S.-L.; Lu, W.-Y.; Liu, M.; Xie, C.; Shi, J.-Y. Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis J. Controlled Release 2008, 131 (1) 77-82 10.1016/j.jconrel.2008.07.021
33. Luttun, A.; Tjwa, M.; Carmeliet, P. Placental Growth Factor (PlGF) and Its Receptor Flt-1 (VEGFR-1) Ann. N. Y. Acad. Sci. 2002, 979 (1) 80-93 10.1111/j.1749-6632.2002.tb04870.x
34. Autiero, M.; Waltenberger, J.; Communi, D.; Kranz, A.; Moons, L.; Lambrechts, D.; Kroll, J.; Plaisance, S.; De Mol, M.; Bono, F. et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 Nat. Med. 2003, 9 (7) 936-943 10.1038/nm884
35. De Falco, S. The discovery of placenta growth factor and its biological activity Exp. Mol. Med. 2012, 44 (1) 1-9 10.3858/emm.2012.44.1.025
36. Pettersson, A.; Nagy, J. A.; Brown, L. F.; Sundberg, C.; Morgan, E.; Jungles, S.; Carter, R.; Krieger, J. E.; Manseau, E. J.; Harvey, V. S. et al. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor Lab. Invest. 2000, 80 (1) 99-115 10.1038/labinvest.3780013
37. Simons, M.; Bonow, R. O.; Chronos, N. A.; Cohen, D. J.; Giordano, F. J.; Hammond, H. K.; Laham, R. J.; Li, W.; Pike, M.; Sellke, F. W. et al. Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus: An Expert Panel Summary Circulation 2000, 102 (11) e73-e86 10.1161/01.CIR.102.11.e73
38. Carmeliet, P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat. Med. 2000, 6 (10) 1102-1103 10.1038/80430
39. Lee, T. T.; García, J. R.; Paez, J. I.; Singh, A.; Phelps, E. A.; Weis, S.; Shafiq, Z.; Shekaran, A.; Del Campo, A.; García, A. J. Light-triggered in vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials Nat. Mater. 2014, 14, 352 10.1038/nmat4157
40. Maess, M. B.; Sendelbach, S.; Lorkowski, S. Selection of reliable reference genes during THP-1 monocyte differentiation into macrophages BMC Mol. Biol. 2010, 11 (1) 90 10.1186/1471-2199-11-90
41. Coleman, D. L.; King, R. N.; Andrade, J. D. The foreign body reaction: a chronic inflammatory response J. Biomed. Mater. Res. 1974, 8 (5) 199-211 10.1002/jbm.820080503
42. Takahashi, H.; Wang, Y.; Grainger, D. W. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation J. Controlled Release 2010, 147 (3) 400-407 10.1016/j.jconrel.2010.08.019
43. Kim, J.; Dadsetan, M.; Ameenuddin, S.; Windebank, A. J.; Yaszemski, M. J.; Lu, L. In vivo biodegradation and biocompatibility of PEG/sebacic acid-based hydrogels using a cage implant system J. Biomed. Mater. Res., Part A 2010, 95 (1) 191-197 10.1002/jbm.a.32810
44. Shao, Q.; Jiang, S. Molecular understanding and design of zwitterionic materials Adv. Mater. 2015, 27 (1) 15-26 10.1002/adma.201404059
45. Grainger, D. W. All charged up about implanted biomaterials Nat. Biotechnol. 2013, 31 (6) 507-509 10.1038/nbt.2600
46. Phelps, E. A.; Landázuri, N.; Thulé, P. M.; Taylor, W. R.; García, A. J. Bioartificial matrices for therapeutic vascularization Proc. Natl. Acad. Sci. U. S. A. 2010, 107 (8) 3323-3328 10.1073/pnas.0905447107
47. Phelps, E. A.; García, A. J. Engineering more than a cell: vascularization strategies in tissue engineering Curr. Opin. Biotechnol. 2010, 21 (5) 704-709 10.1016/j.copbio.2010.06.005
48. Webber, M. J.; Tongers, J.; Newcomb, C. J.; Marquardt, K.-T.; Bauersachs, J.; Losordo, D. W.; Stupp, S. I. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair Proc. Natl. Acad. Sci. U. S. A. 2011, 108 (33) 13438-13443 10.1073/pnas.1016546108
49. Ehrbar, M.; Djonov, V. G.; Schnell, C.; Tschanz, S. A.; Martiny-Baron, G.; Schenk, U.; Wood, J.; Burri, P. H.; Hubbell, J. A.; Zisch, A. H. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth Circ. Res. 2004, 94 (8) 1124-1132 10.1161/01.RES.0000126411.29641.08
50. Zisch, A. H.; Lutolf, M. P.; Ehrbar, M.; Raeber, G. P.; Rizzi, S. C.; Davies, N.; Schmökel, H.; Bezuidenhout, D.; Djonov, V.; Zilla, P. et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth FASEB J. 2003, 17 (15) 2260-2262 10.1096/fj.02-1041fje
51. Meyer, J.; Whitcomb, L.; Collins, D. Efficient encapsulation of proteins within liposomes for slow release in vivo Biochem. Biophys. Res. Commun. 1994, 199 (2) 433-438 10.1006/bbrc.1994.1247
52. Scott, R. C.; Rosano, J. M.; Ivanov, Z.; Wang, B.; Chong, P. L.-G.; Issekutz, A. C.; Crabbe, D. L.; Kiani, M. F. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function FASEB J. 2009, 23 (10) 3361-3367 10.1096/fj.08-127373
53. Alemdaroʇlu, C.; Degim, Z.; Celebi, N.; Sengezer, M.; Alömeroglu, M.; Nacar, A. Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing J. Biomed. Mater. Res., Part A 2008, 85 (1) 271-283 10.1002/jbm.a.31588
54. Segers, V. F. M.; Lee, R. T. Local delivery of proteins and the use of self-assembling peptides Drug Discovery Today 2007, 12 (13-14) 561-568 10.1016/j.drudis.2007.05.003
55. Miller, R. E.; Kopesky, P. W.; Grodzinsky, A. J. Growth factor delivery through self-assembling peptide scaffolds Clin. Orthop. Relat. Res. 2011, 469 (10) 2716-2724 10.1007/s11999-011-1891-1
56. Schneider, A.; Garlick, J. A.; Egles, C. Self-assembling peptide nanofiber scaffolds accelerate wound healing PLoS One 2008, 3 (1) e1410 10.1371/journal.pone.0001410
57. Hsieh, P. C. H.; Davis, M. E.; Gannon, J.; MacGillivray, C.; Lee, R. T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers J. Clin. Invest. 2006, 116 (1) 237-248 10.1172/JCI25878
58. Segers, V. F. M.; Tokunou, T.; Higgins, L. J.; MacGillivray, C.; Gannon, J.; Lee, R. T. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 2007, 116 (15) 1683-1692 10.1161/CIRCULATIONAHA.107.718718
59. Davis, M. E.; Hsieh, P. C. H.; Takahashi, T.; Song, Q.; Zhang, S.; Kamm, R. D.; Grodzinsky, A. J.; Anversa, P.; Lee, R. T. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction Proc. Natl. Acad. Sci. U. S. A. 2006, 103 (21) 8155-8160 10.1073/pnas.0602877103
60. Franssen, O.; Vandervennet, L.; Roders, P.; Hennink, W. E. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres J. Controlled Release 1999, 60 (2-3) 211-221 10.1016/S0168-3659(99)00074-7
61. Nasongkla, N.; Bey, E.; Ren, J.; Ai, H.; Khemtong, C.; Guthi, J. S.; Chin, S.-F.; Sherry, A. D.; Boothman, D. A.; Gao, J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems Nano Lett. 2006, 6 (11) 2427-2430 10.1021/nl061412u
62. Lee, J. S.; Go, D. H.; Bae, J. W.; Lee, S. J.; Park, K. D. Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor J. Controlled Release 2007, 117 (2) 204-209 10.1016/j.jconrel.2006.11.004
63. Chappell, J. C.; Song, J.; Burke, C. W.; Klibanov, A. L.; Price, R. J. Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis Small 2008, 4 (10) 1769-1777 10.1002/smll.200800806
64. Zhang, S.; Uludaʇ, H. Nanoparticulate systems for growth factor delivery Pharm. Res. 2009, 26 (7) 1561-1580 10.1007/s11095-009-9897-z
65. Zisch, A. H.; Schenk, U.; Schense, J. C.; Sakiyama-Elbert, S. E.; Hubbell, J. A. Covalently conjugated VEGF-fibrin matrices for endothelialization J. Controlled Release 2001, 72 (1-3) 101-113 10.1016/S0168-3659(01)00266-8
66. Chen, F.-M.; Zhang, M.; Wu, Z.-F. Toward delivery of multiple growth factors in tissue engineering Biomaterials 2010, 31 (24) 6279-6308 10.1016/j.biomaterials.2010.04.053
67. Fujita, M.; Ishihara, M.; Simizu, M.; Obara, K.; Ishizuka, T.; Saito, Y.; Yura, H.; Morimoto, Y.; Takase, B.; Matsui, T. et al. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel Biomaterials 2004, 25 (4) 699-706 10.1016/S0142-9612(03)00557-X